top of page

Search

Microvascular Therapeutics receives funds from Commercialization Readiness Program

MVT
Apr 11, 2022
0 min read

Recent Posts

ASE Meeting: Post- Presentation News Article

https://conexiant.com/cardiology/articles/early-phase-data-support-novel-contrast-agent/

Late Breaking Abstract Presentation by our CEO at the ASE meeting

Microvascular Therapeutics' CEO, Dr. Evan C Unger, featured in Authority Magazine.

Microvascular Therapeutics' CEO, Dr. Evan C Unger, featured in Authority Magazine.

Comments

bottom of page